Construction and immunogenicity of a T cell epitope-based subunit vaccine candidate against Mycobacterium tuberculosis

Despite antibiotic treatment and Bacille Calmette-Guerin (BCG) vaccination, Mycobacterium tuberculosis remains a major public health burden in most developing countries. Therefore, developing an improved vaccine is high priority. In this study, we cloned the genes of the immunodominant antigen of M. tuberculosis viz. its 38-kDa antigen (Pst homolog) (Rv0934, PstS1), and its T cell epitopes (amino acid [aa]169- 405 and [aa]802-1119), which we termed PstS1p. Prokaryotic expression showed that the two recombinant proteins were mainly in the form of inclusion bodies. We also evaluated the immunity and immunogenicity of PstS1 and PstS1p. Both PstS1 and its T cell epitopes elicited significantly higher antigen specific immunoglobulin G (IgG) antibodies in mouse serum, indicating that they enhanced antibody response. They also elicited the T helper 1 (Th1)-type response and promoted CD4(+) T cell proliferation. Compared to PstS1, PstS1p promoted stronger cell-mediated immune response. These data indicate that PstS1p is highly immunogenic in mice, and may be a promising candidate vaccine for controlling tuberculosis. (C) 2021 Published by Elsevier Ltd.

Automated summary

This study cloned the genes of the immunodominant antigen of M. tuberculosis and evaluated the immunity and immunogenicity of PstS1 and PstS1p. The results indicate that PstS1p is highly immunogenic in mice and may be a promising candidate vaccine for controlling tuberculosis.